Literature DB >> 4340163

Activating and protective capacities of a purified electrophoretic fraction of murine leukemia virus for murine leukemia virus infectivity.

P J Fischinger, J Lange, W Schäfer.   

Abstract

A highly purified gel electrophoretic fraction of murine leukemia virus (MuLV) can confer enhanced infectivity on MuLV derived from tissue culture and can protect MuLV from neutralization by specific antiserum. Of the known viral proteins tested, a purified electrophoretic fraction (14,000 daltons) is the only active fraction and seems to consist of the group-specific antigen I and an associated lipid moiety. The action of this fraction obtained from one type of MuLV is group-specific in that it can enhance and protect serologically different types of MuLV. The effect of this fraction is exerted on viruses and not on cells. MuLV derived from tumors was not enhanced by the fraction, but became amenable to its action after a single passage through tissue culture. Reconstruction experiments suggested that the fraction may consist of an exterior protein associated with some lipids. This complex, which apparently protrudes on the viral surface, is required for infectivity and shields the type-specific antigen containing the hemagglutinating site.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4340163      PMCID: PMC426828          DOI: 10.1073/pnas.69.7.1900

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  19 in total

1.  Isolation of murine sarcoma virus-transformed mouse cells which are negative for leukemia virus from agar suspension cultures.

Authors:  R H Bassin; N Tuttle; P J Fischinger
Journal:  Int J Cancer       Date:  1970-07-15       Impact factor: 7.396

2.  Shared viral antigen of mammalian leukaemia viruses.

Authors:  G Geering; T Aoki; L J Old
Journal:  Nature       Date:  1970-04-18       Impact factor: 49.962

3.  [Studies on mouse leukemia viruses. II. Demonstration of a virus-specific hemagglutinin].

Authors:  W Schäfer; J Szántó
Journal:  Z Naturforsch B       Date:  1969-10       Impact factor: 1.047

4.  Some characteristics of an isolated group antigen common to most strains of murine leukemia virus.

Authors:  M A Fink; L R Sibal; N A Wivel; C A Cowles; T E O'Conner
Journal:  Virology       Date:  1969-04       Impact factor: 3.616

5.  Shared group-specific antigen of murine and feline leukemia viruses.

Authors:  G Geering; W D Hardy; L J Old; E de Harven; R S Brodey
Journal:  Virology       Date:  1968-12       Impact factor: 3.616

6.  Studies on mouse leukemia viruses. I. Isolation and characterization of a group-specific antigen.

Authors:  W Schäfer; F A Anderer; H Bauer; L Pister
Journal:  Virology       Date:  1969-07       Impact factor: 3.616

7.  Enhancing effect of diethylaminoethyl-dextran on the focus-forming titer of a murine sarcoma virus (Harvey strain).

Authors:  H Duc-Nguyen
Journal:  J Virol       Date:  1968-06       Impact factor: 5.103

8.  Isolation and some characteristics of a group-specific antigen of the murine leukemia viruses.

Authors:  A Gregoriades; L J Old
Journal:  Virology       Date:  1969-02       Impact factor: 3.616

9.  Isolation and identification of a helper virus found in the Moloney sarcoma-leukemia virus complex.

Authors:  P J Fischinger; C O Moore; T E O'Connor
Journal:  J Natl Cancer Inst       Date:  1969-04       Impact factor: 13.506

10.  Antigens of leukemias induced by naturally occurring murine leukemia virus: their relation to the antigens of gross virus and other murine leukemia viruses.

Authors:  G Geering; L J Old; E A Boyse
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more
  1 in total

1.  Properties of feline leukemia virus. I. Chromatographic separation and analysis of the polypeptides.

Authors:  D C Graves; L F Velicer
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.